Colorectal Cancer
Liquid Biopsy-Guided EGFR Rechallenge Therapy Shows Benefit for Colorectal Cancer Patients
The first interventional trial to use ctDNA to recruit eligible patients for this treatment showed 30 percent observable responses and more than 60 percent disease control.
Oncocyte, Italian Foundation to Investigate DetermaIO in Colorectal Cancer
The Italian research group will evaluate the ability of Oncocyte's gene expression assay in samples from immunotherapy trials for advanced colorectal cancer patients.
The talks focused on studies stemming from the Cancer Moonshot initiative's Human Tumor Atlas Network project, which is readying its first data release.
Colorectal Cancer Relapse Can Be Predicted by ctDNA Clearance, Study Shows
Researchers found patients who had remaining ctDNA after surgery and adjuvant chemo were 12 times more likely to experience recurrence than ctDNA-negative patients.
The data, while limited, indicate that the firm's blood-only assay may be able to match the performance of existing commercial tissue-informed competitors.